$282 Million is the total value of MPM BioImpact LLC's 12 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HARP | New | Harpoon Therapeutics, Inc. | $57,658,000 | – | 3,898,422 | +100.0% | 20.43% | – |
| EPZM | New | Epizyme, Inc. | $57,356,000 | – | 2,331,534 | +100.0% | 20.33% | – |
| TCRR | New | TCR2 Therapeutics, Inc. | $48,138,000 | – | 3,370,982 | +100.0% | 17.06% | – |
| GTHX | New | G1 Therapeutics, Inc. | $37,631,000 | – | 1,423,794 | +100.0% | 13.34% | – |
| ARQL | New | ArQule, Inc. | $21,840,000 | – | 1,094,210 | +100.0% | 7.74% | – |
| New | MEI Pharma, Inc. | $15,500,000 | – | 6,250,000 | +100.0% | 5.49% | – | |
| DCPH | New | Deciphera Pharmaceuticals, Inc. | $13,417,000 | – | 215,570 | +100.0% | 4.76% | – |
| ARGX | New | argenx SE | $11,509,000 | – | 71,700 | +100.0% | 4.08% | – |
| YMAB | New | YmAbs Therapeutics, Inc. | $10,540,000 | – | 337,291 | +100.0% | 3.74% | – |
| CTMX | New | CytomX Therapeutics, Inc. | $7,109,000 | – | 855,437 | +100.0% | 2.52% | – |
| SNSS | New | Sunesis Pharmaceuticals, Inc. | $949,000 | – | 2,809,912 | +100.0% | 0.34% | – |
| AUTL | New | Autolus Therapeutics Limited | $525,000 | – | 39,740 | +100.0% | 0.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Harpoon Therapeutics, Inc. | 15 | Q2 2023 | 27.6% |
| Repare Therapeutics, Inc. | 14 | Q3 2023 | 19.7% |
| TCR2 Therapeutics, Inc. | 14 | Q1 2023 | 18.0% |
| iTeos Therapeutics, Inc. | 13 | Q3 2023 | 15.7% |
| G1 Therapeutics, Inc. | 13 | Q4 2022 | 13.3% |
| Y Mabs Therapeutics, Inc. | 12 | Q3 2022 | 5.4% |
| Cullinan Oncology, Inc. | 11 | Q3 2023 | 41.4% |
| Epizyme, Inc. | 11 | Q2 2022 | 22.1% |
| Oncorus, Inc. | 11 | Q2 2023 | 13.3% |
| Intellia Therapeutics, Inc. | 10 | Q3 2023 | 5.5% |
View MPM BioImpact LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-08-01 |
| SC 13D | 2023-06-12 |
| 4 | 2023-06-05 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
View MPM BioImpact LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.